In addition, it has been observed that in tumor cells, the increased expression of receptors such as KIR and CD94/NKG2A is associated with an inhibitory phenotype that reduces NK cell cytotoxicity in the tumor microenvironment [2,18,19,20]. This evidence concerns the gene KLRC1 and neoplasm.